Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Aggressive LDL-C Lowering and the Brain: Impact on Risk for Dementia and Hemorrhagic Stroke: A Scientific Statement From the American Heart Association
Larry B. Goldstein, Peter P. Tóth, Jennifer L. Dearborn, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2023) Vol. 43, Iss. 10
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Long-Term Lipid Lowering With Evolocumab in Older Individuals
Samer Al Said, Michelle L. O’Donoghue, Xinhui Ran, et al.
Journal of the American College of Cardiology (2025) Vol. 85, Iss. 5, pp. 504-512
Closed Access | Times Cited: 2
Advances in targeting LDL cholesterol: PCSK9 inhibitors and beyond
Maya Safarova, Tia Bimal, Daniel Soffer, et al.
American Journal of Preventive Cardiology (2024) Vol. 19, pp. 100701-100701
Open Access | Times Cited: 13
Vascular cognitive impairment and dementia: Mechanisms, treatment, and future directions
Vincent Mok, Cai Yuan, Hugh S Markus
International Journal of Stroke (2024) Vol. 19, Iss. 8, pp. 838-856
Closed Access | Times Cited: 12
2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP)
Maciej Banach, Željko Reiner, Stanisław Surma, et al.
Drugs (2024)
Open Access | Times Cited: 9
Associations between Ambient Benzene and Stroke, and the Mediating Role of Accelerated Biological Aging: Findings from the UK Biobank.
Guixiang Ji, Yiyi Wang, Zhixi Lu, et al.
Environmental Pollution (2025) Vol. 367, pp. 125656-125656
Closed Access | Times Cited: 1
Hypercholesterolemia and the Increased Risk of Vascular Dementia: a Cholesterol Perspective
Guojiao Shang, Qi Shao, Kai Lv, et al.
Current Atherosclerosis Reports (2024) Vol. 26, Iss. 8, pp. 435-449
Closed Access | Times Cited: 8
Current and Future Treatments of Vascular Cognitive Impairment
Bonaventure Ip, Ho Ko, Bonnie Yin Ka Lam, et al.
Stroke (2024) Vol. 55, Iss. 4, pp. 822-839
Closed Access | Times Cited: 7
Rationale and Design of the Statin Use in Intracerebral Hemorrhage Patients (SATURN) Trial
Sarah Marchina, Sharon D. Yeatts, Lydia D. Foster, et al.
Cerebrovascular Diseases (2024), pp. 1-1
Closed Access | Times Cited: 4
Evolution of More Aggressive LDL-Cholesterol Targets and Therapies for Cardiovascular Disease Prevention
Jeffrey E. Jones, Kevin Tang, Ailin Barseghian, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 23, pp. 7432-7432
Open Access | Times Cited: 10
The role of statins in dementia or Alzheimer’s disease incidence: a systematic review and meta-analysis of cohort studies
Ye Du, Zhangjie Yu, Chengyi Li, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Reducing LDL-Cholesterol to Very Low Levels: Sailing Between Established Benefits and Potential Risks
Stefania Angela Di Fusco, Massimo Volpe, Federico Nardi, et al.
High Blood Pressure & Cardiovascular Prevention (2025)
Closed Access
Emerging risks of lipid-lowering therapy and low LDL levels: implications for eye, brain, and new-onset diabetes
Erkan Cüre, Medine Cumhur Cüre
Lipids in Health and Disease (2025) Vol. 24, Iss. 1
Open Access
Association of LDL-cholesterol <1.8 mmol/L and statin use with the recurrence of intracerebral hemorrhage
T LEE, William Leung, Chun Ho, et al.
International Journal of Stroke (2024) Vol. 19, Iss. 6, pp. 695-704
Closed Access | Times Cited: 3
Outcomes of Patients with Normal LDL-Cholesterol at Admission for Acute Coronary Syndromes: Lower Is Not Always Better
Ivana Jurin, Anđela Jurišić, Igor Rudež, et al.
Journal of Cardiovascular Development and Disease (2024) Vol. 11, Iss. 4, pp. 120-120
Open Access | Times Cited: 3
Association between dietary intake of niacin and stroke in the US residents: evidence from national health and nutrition examination survey (NHANES) 1999–2018
Jie-Yu Qiu, Wenhui Zhang, Zhu Xiao-ming, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 3
Treating Hypercholesterolemia in Older Adults for Primary Prevention of Cardiovascular Events
Awsse Al-Ani, Yasser Jamil, Ariela R. Orkaby
Drugs & Aging (2024) Vol. 41, Iss. 9, pp. 699-712
Closed Access | Times Cited: 3
Effectiveness of treat-to-target cholesterol-lowering interventions on cardiovascular disease and all-cause mortality risk in the community-dwelling population: a target trial emulation
Zhao Yang, Qiujv Deng, Yongchen Hao, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Critical Challenges of Intravenous Nanomaterials Crossing the Blood‐Brain Barrier: from Blood to Brain
Weikang Luo, Cong Chen, Xin Guo, et al.
Advanced Functional Materials (2024)
Closed Access | Times Cited: 3
Closing the gap between guidelines and clinical practice for managing dyslipidemia: where are we now?
Sohum Sheth, Maciej Banach, Peter P. Tóth
Expert Review of Cardiovascular Therapy (2024) Vol. 22, Iss. 9, pp. 441-457
Closed Access | Times Cited: 2
Long-Term Cognitive Safety of Achieving Very Low LDL Cholesterol with Evolocumab
André Zimerman, Michelle L. O’Donoghue, Xinhui Ran, et al.
NEJM Evidence (2024) Vol. 4, Iss. 1
Closed Access | Times Cited: 2
The functions of apolipoproteins and lipoproteins in health and disease
Zijun Ma, Jixin Zhong, Wei Tu, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 2
Association between atherogenic index of plasma and post-stroke depression: a cross-sectional study
Demin Kong, Wei Zou
European journal of psychotraumatology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Cholesterol Lowering in Older Adults: Should We Wait for Further Evidence?
Yasser Jamil, Rachel S. Cohen, Dana K. Alameddine, et al.
Current Atherosclerosis Reports (2024) Vol. 26, Iss. 9, pp. 521-536
Closed Access | Times Cited: 1
Rationale for Increasing Doses of Statins in Everyday Clinical Practice
Andrey V. Susekov
Kardiologiia (2024) Vol. 64, Iss. 8, pp. 79-88
Closed Access | Times Cited: 1
Do Statins Affect Cognitive Health? A Narrative Review and Critical Analysis of the Evidence
Richard Kazibwe, Rishi Rikhi, Saeid Mirzai, et al.
Current Atherosclerosis Reports (2024) Vol. 27, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top